Literature DB >> 25652671

Measurement of Shrinkage and Cracking in Lyophilized Amorphous Cakes. Part II: Kinetics.

Sabine Ullrich1, Stefan Seyferth, Geoffrey Lee.   

Abstract

PURPOSE: Measurement of the kinetic development of shrinkage and cracking of an amorphous trehalose cake as they take place during lyophilization.
METHODS: A novel technique has been developed which monitors a vial in situ during the freeze-drying cycle. The 2-dimensional degrees of shrinkage and cracking in its top surface are determined quantitatively using a digital camera and evaluated using AxioVision.
RESULTS: Shrinkage and cracking develop largely already during programmed primary drying and are coupled. For trehalose, sucrose and maltose no clear correlation between shrinkage and wg' is found. There is no dependence of cake rim detachment from the vial inner surface on the trehalose concentration. Cake adhesion is therefore likely not the only determining factor for detachment and shrinkage.
CONCLUSIONS: If shrinkage can occur during primary drying, then this relaxes the drying tension produced by desorption of non-frozen water out of the amorphous structure left behind as the sublimation front passes through a volume element, and causes little or no cracking. If shrinkage is restrained, then the drying tension is relaxed by cracking of the brittle cake.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25652671     DOI: 10.1007/s11095-015-1639-9

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  8 in total

1.  Continuous measurement of drying rate of crystalline and amorphous systems during freeze-drying using an in situ microbalance technique.

Authors:  C Roth; G Winter; G Lee
Journal:  J Pharm Sci       Date:  2001-09       Impact factor: 3.534

Review 2.  Design of freeze-drying processes for pharmaceuticals: practical advice.

Authors:  Xiaolin Tang; Michael J Pikal
Journal:  Pharm Res       Date:  2004-02       Impact factor: 4.200

3.  Cake shrinkage during freeze drying: a combined experimental and theoretical study.

Authors:  S Rambhatla; J P Obert; S Luthra; C Bhugra; Michael J Pikal
Journal:  Pharm Dev Technol       Date:  2005       Impact factor: 3.133

4.  Why do drying films crack?

Authors:  Wai Peng Lee; Alexander F Routh
Journal:  Langmuir       Date:  2004-11-09       Impact factor: 3.882

5.  Determination of end point of primary drying in freeze-drying process control.

Authors:  Sajal M Patel; Takayuki Doen; Michael J Pikal
Journal:  AAPS PharmSciTech       Date:  2010-01-08       Impact factor: 3.246

6.  Use of manometric temperature measurements (MTM) to characterize the freeze-drying behavior of amorphous protein formulations.

Authors:  Robert E Johnson; Megan E Oldroyd; Saleem S Ahmed; Henning Gieseler; Lavinia M Lewis
Journal:  J Pharm Sci       Date:  2010-06       Impact factor: 3.534

Review 7.  Emerging freeze-drying process development and scale-up issues.

Authors:  Sajal Manubhai Patel; Michael J Pikal
Journal:  AAPS PharmSciTech       Date:  2011-02-23       Impact factor: 3.246

8.  Measurement of shrinkage and cracking in lyophilized amorphous cakes. Part I: final-product assessment.

Authors:  Sabine Ullrich; Stefan Seyferth; Geoffrey Lee
Journal:  J Pharm Sci       Date:  2014-11-24       Impact factor: 3.534

  8 in total
  3 in total

1.  4D Micro-Computed X-ray Tomography as a Tool to Determine Critical Process and Product Information of Spin Freeze-Dried Unit Doses.

Authors:  Brecht Vanbillemont; Joris Lammens; Wannes Goethals; Chris Vervaet; Matthieu N Boone; Thomas De Beer
Journal:  Pharmaceutics       Date:  2020-05-07       Impact factor: 6.321

2.  Be Aggressive! Amorphous Excipients Enabling Single-Step Freeze-Drying of Monoclonal Antibody Formulations.

Authors:  Christina Haeuser; Pierre Goldbach; Joerg Huwyler; Wolfgang Friess; Andrea Allmendinger
Journal:  Pharmaceutics       Date:  2019-11-17       Impact factor: 6.321

3.  Spin Freezing and Its Impact on Pore Size, Tortuosity and Solid State.

Authors:  Joris Lammens; Niloofar Moazami Goudarzi; Laurens Leys; Gust Nuytten; Pieter-Jan Van Bockstal; Chris Vervaet; Matthieu N Boone; Thomas De Beer
Journal:  Pharmaceutics       Date:  2021-12-09       Impact factor: 6.321

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.